Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

NCT06452537 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Interventions

DRUG: Tocilizumab
DRUG: Prednisone

Sponsor

Tianjin Medical University General Hospital